Summary
Objectives:
- Screen and identify patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
- Describe current disparities in care in MASLD risk, assessment, and management.
- Manage contributing risk factors to MASLD in patient care.
- Counsel patients on current risks, treatment options, and prognosis.
Note: If you share or use these presentations, or any parts thereof, please ensure you always credit the Ohio Cardiovascular and Diabetes Health Collaborative (Cardi-OH) and provide a link to Cardi-OH.org. CME is not offered for viewing the recording.
Featured Speakers
Lanla F. Conteh, MD, MPH
The Ohio State University College of Medicine